Cargando…

Chemotherapy response prediction with diffuser elapser network

In solid tumors, elevated fluid pressure and inadequate blood perfusion resulting from unbalanced angiogenesis are the prominent reasons for the ineffective drug delivery inside tumors. To normalize the heterogeneous and tortuous tumor vessel structure, antiangiogenic treatment is an effective appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyuncu, Batuhan, Melek, Ahmet, Yilmaz, Defne, Tuzer, Mert, Unlu, Mehmet Burcin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803972/
https://www.ncbi.nlm.nih.gov/pubmed/35102179
http://dx.doi.org/10.1038/s41598-022-05460-z
_version_ 1784642987754520576
author Koyuncu, Batuhan
Melek, Ahmet
Yilmaz, Defne
Tuzer, Mert
Unlu, Mehmet Burcin
author_facet Koyuncu, Batuhan
Melek, Ahmet
Yilmaz, Defne
Tuzer, Mert
Unlu, Mehmet Burcin
author_sort Koyuncu, Batuhan
collection PubMed
description In solid tumors, elevated fluid pressure and inadequate blood perfusion resulting from unbalanced angiogenesis are the prominent reasons for the ineffective drug delivery inside tumors. To normalize the heterogeneous and tortuous tumor vessel structure, antiangiogenic treatment is an effective approach. Additionally, the combined therapy of antiangiogenic agents and chemotherapy drugs has shown promising effects on enhanced drug delivery. However, the need to find the appropriate scheduling and dosages of the combination therapy is one of the main problems in anticancer therapy. Our study aims to generate a realistic response to the treatment schedule, making it possible for future works to use these patient-specific responses to decide on the optimal starting time and dosages of cytotoxic drug treatment. Our dataset is based on our previous in-silico model with a framework for the tumor microenvironment, consisting of a tumor layer, vasculature network, interstitial fluid pressure, and drug diffusion maps. In this regard, the chemotherapy response prediction problem is discussed in the study, putting forth a proof of concept for deep learning models to capture the tumor growth and drug response behaviors simultaneously. The proposed model utilizes multiple convolutional neural network submodels to predict future tumor microenvironment maps considering the effects of ongoing treatment. Since the model has the task of predicting future tumor microenvironment maps, we use two image quality evaluation metrics, which are structural similarity and peak signal-to-noise ratio, to evaluate model performance. We track tumor cell density values of ground truth and predicted tumor microenvironments. The model predicts tumor microenvironment maps seven days ahead with the average structural similarity score of 0.973 and the average peak signal ratio of 35.41 in the test set. It also predicts tumor cell density at the end day of 7 with the mean absolute percentage error of [Formula: see text] .
format Online
Article
Text
id pubmed-8803972
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88039722022-02-01 Chemotherapy response prediction with diffuser elapser network Koyuncu, Batuhan Melek, Ahmet Yilmaz, Defne Tuzer, Mert Unlu, Mehmet Burcin Sci Rep Article In solid tumors, elevated fluid pressure and inadequate blood perfusion resulting from unbalanced angiogenesis are the prominent reasons for the ineffective drug delivery inside tumors. To normalize the heterogeneous and tortuous tumor vessel structure, antiangiogenic treatment is an effective approach. Additionally, the combined therapy of antiangiogenic agents and chemotherapy drugs has shown promising effects on enhanced drug delivery. However, the need to find the appropriate scheduling and dosages of the combination therapy is one of the main problems in anticancer therapy. Our study aims to generate a realistic response to the treatment schedule, making it possible for future works to use these patient-specific responses to decide on the optimal starting time and dosages of cytotoxic drug treatment. Our dataset is based on our previous in-silico model with a framework for the tumor microenvironment, consisting of a tumor layer, vasculature network, interstitial fluid pressure, and drug diffusion maps. In this regard, the chemotherapy response prediction problem is discussed in the study, putting forth a proof of concept for deep learning models to capture the tumor growth and drug response behaviors simultaneously. The proposed model utilizes multiple convolutional neural network submodels to predict future tumor microenvironment maps considering the effects of ongoing treatment. Since the model has the task of predicting future tumor microenvironment maps, we use two image quality evaluation metrics, which are structural similarity and peak signal-to-noise ratio, to evaluate model performance. We track tumor cell density values of ground truth and predicted tumor microenvironments. The model predicts tumor microenvironment maps seven days ahead with the average structural similarity score of 0.973 and the average peak signal ratio of 35.41 in the test set. It also predicts tumor cell density at the end day of 7 with the mean absolute percentage error of [Formula: see text] . Nature Publishing Group UK 2022-01-31 /pmc/articles/PMC8803972/ /pubmed/35102179 http://dx.doi.org/10.1038/s41598-022-05460-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Koyuncu, Batuhan
Melek, Ahmet
Yilmaz, Defne
Tuzer, Mert
Unlu, Mehmet Burcin
Chemotherapy response prediction with diffuser elapser network
title Chemotherapy response prediction with diffuser elapser network
title_full Chemotherapy response prediction with diffuser elapser network
title_fullStr Chemotherapy response prediction with diffuser elapser network
title_full_unstemmed Chemotherapy response prediction with diffuser elapser network
title_short Chemotherapy response prediction with diffuser elapser network
title_sort chemotherapy response prediction with diffuser elapser network
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803972/
https://www.ncbi.nlm.nih.gov/pubmed/35102179
http://dx.doi.org/10.1038/s41598-022-05460-z
work_keys_str_mv AT koyuncubatuhan chemotherapyresponsepredictionwithdiffuserelapsernetwork
AT melekahmet chemotherapyresponsepredictionwithdiffuserelapsernetwork
AT yilmazdefne chemotherapyresponsepredictionwithdiffuserelapsernetwork
AT tuzermert chemotherapyresponsepredictionwithdiffuserelapsernetwork
AT unlumehmetburcin chemotherapyresponsepredictionwithdiffuserelapsernetwork